Why Apparent Binding Strength Has More Than One Cause
A bispecific antibody can appear to bind a target tightly for at least two distinct reasons. Its individual binding arm may have stronger intrinsic affinity, or multivalent engagement may stabilize binding through simultaneous bonds and rebinding. These mechanisms can produce similar-looking increases in cell binding or slower loss of signal after washout, but they imply different behavior when target density or valency changes.
The distinction matters when interpreting bispecific-antibody data. A low apparent concentration for half-maximal cell binding is not, by itself, a measurement of monovalent affinity. The result can depend on arm properties, the number and arrangement of accessible targets, and the time allowed for rebinding. The most informative analysis combines a monovalent binding measurement with washout and target-density comparisons.
What Each Measurement Can Establish
For a single binding site interacting reversibly with one class of independent target sites at equilibrium, the fraction of sites occupied at free antibody concentration \(C\) is
This Langmuir relationship assumes equilibrium, a 1:1 interaction, no cooperativity, and a known free concentration. A fitted \(K_D\) has an intrinsic-affinity interpretation only when the assay actually isolates that interaction. A cell-surface binding curve for a multivalent antibody may instead return an apparent concentration parameter that also reflects avidity, target density, and assay conditions.
A useful strategy is to compare the same binding arm in a format that permits only one arm-target interaction, such as an isolated arm or suitable monovalent fragment, with the intact bispecific. The comparison should preserve the relevant epitope and use compatible assay conditions. If the isolated-arm \(K_D\), \(k_{\mathrm{on}}\), and \(k_{\mathrm{off}}\) are unchanged but the intact molecule binds more persistently on target-rich cells, avidity is a plausible explanation. If the isolated arm itself has a smaller \(K_D\), stronger intrinsic affinity is supported.
Worked Example: Testing for a Change in Intrinsic Affinity
Two hypothetical bispecific variants, A and B, have the same format. Their target-binding arms are tested in a monovalent assay. For A, the measured \(k_{\mathrm{on}}\) is \(2.0\times10^5\ \mathrm{M^{-1}s^{-1}}\) and \(k_{\mathrm{off}}\) is \(2.0\times10^{-3}\ \mathrm{s^{-1}}\). For B, the corresponding values are \(2.0\times10^5\ \mathrm{M^{-1}s^{-1}}\) and \(5.0\times10^{-4}\ \mathrm{s^{-1}}\). Calculate each \(K_D\).
For A:
For B:
Under the simple 1:1 model and these assay conditions, B has fourfold stronger intrinsic affinity: its \(K_D\) is one quarter of A's. This conclusion concerns the isolated interaction. Cell-surface data are still needed to determine whether avidity also contributes to intact-molecule binding.
Why Valency and Target Density Matter
When one arm of a multivalent molecule binds, another arm may encounter a nearby target. The local concentration of reachable targets can be much greater than their bulk concentration; it is often represented conceptually by an effective local concentration, \(C_{\mathrm{eff}}\). Once the first bond forms, the second bond can therefore form readily if the geometry permits. After one bond breaks, the remaining bond can keep the molecule near the surface long enough for the broken bond to reform.
A simplified conditional model makes the effect clear. Suppose one bond is already formed, the second arm can bind with dissociation constant \(K_D\), and the reachable target concentration is \(C_{\mathrm{eff}}\). The ratio of doubly bound to singly bound states is approximately \(C_{\mathrm{eff}}/K_D\). If these are the only two states considered, the fraction of anchored molecules that are doubly bound is
This is a conditional, simplified result, not a universal formula for the intact molecule's apparent \(K_D\). It assumes the first bond is already present, treats the second target concentration as fixed, and omits geometric heterogeneity and competition. Its value is that it shows why increasing the availability of nearby targets can increase the doubly bound fraction without changing either arm's intrinsic affinity.
Worked Example: Target Proximity Changes the Doubly Bound Fraction
Assume a hypothetical arm has \(K_D=10\ \mathrm{nM}\). After the first arm binds, suppose nearby-target availability corresponds to \(C_{\mathrm{eff}}=100\ \mathrm{nM}\) in a high-density setting and \(C_{\mathrm{eff}}=2\ \mathrm{nM}\) in a low-density setting. Apply the conditional model.
At high density:
At low density:
In this illustrative model, about 90.9% of anchored molecules are doubly bound in the high-density setting, compared with about 16.7% in the low-density setting. The arm's \(K_D\) remains \(10\ \mathrm{nM}\) in both settings. The difference arises from the assumed availability of a second target, not from a change in intrinsic affinity.
Using Washout to Separate the Mechanisms
Washout measures how quickly bound signal declines after free antibody is removed or greatly reduced. For a single reversible bond under sink conditions, negligible rebinding, and a stable target population, the bound fraction declines approximately as
Here \(B(0)\) is the bound amount at washout start, and \(t\) is time. A smaller fitted dissociation rate indicates slower loss under the assay conditions. It indicates stronger intrinsic affinity only if the measurement isolates the monovalent interaction; in a multivalent setting, the fitted rate may be an effective rate shaped by avidity.
An idealized two-bond example illustrates the difference. Starting from a doubly bound state with two equivalent bonds, the first bond breaks at total rate \(2k_{\mathrm{off}}\). The molecule then has one remaining bond. If that bond breaks at rate \(k_{\mathrm{off}}\) and the broken arm rebinds at rate \(k_{\mathrm{on}}C_{\mathrm{eff}}\), the probability of losing the remaining bond before rebinding is
If the singly bound state is short-lived relative to the doubly bound state, a useful approximation is
This approximation assumes equivalent independent bonds, a reachable second target, and negligible rebinding from bulk after complete detachment. It is not a general kinetic model for every bispecific geometry. It does show how the effective washout rate can fall as local rebinding becomes more likely, even when the monovalent \(k_{\mathrm{off}}\) is unchanged.
Worked Example: Density-Dependent Washout Suggests Avidity
Two hypothetical molecules have the same isolated-arm \(k_{\mathrm{off}}=0.010\ \mathrm{min^{-1}}\). Under matched washout conditions, molecule X has a fitted effective rate of \(0.0090\ \mathrm{min^{-1}}\) on low-density cells and \(0.0020\ \mathrm{min^{-1}}\) on high-density cells. Molecule Y has rates of \(0.0085\ \mathrm{min^{-1}}\) and \(0.0080\ \mathrm{min^{-1}}\), respectively. Calculate the apparent dissociation half-lives using \(t_{1/2}=\ln(2)/k_{\mathrm{off,eff}}\).
For X on low-density cells, \(t_{1/2}=0.693/0.0090=77.0\) minutes. On high-density cells, \(t_{1/2}=0.693/0.0020=347\) minutes. Its effective washout is therefore much slower at high target density.
For Y, the corresponding half-lives are \(0.693/0.0085=81.5\) minutes at low density and \(0.693/0.0080=86.6\) minutes at high density. Y's washout changes comparatively little with density.
Because the isolated-arm dissociation rates are matched, X's pronounced density dependence is consistent with multivalent stabilization or rebinding. It does not prove avidity by itself: density-dependent internalization, target turnover, or assay geometry could also affect the observed signal and must be controlled.
Read Binding and Functional Responses Together
A target-density series provides another useful test. With the same antibody concentration range, measure cell binding on cells with low, intermediate, and high target abundance. A multivalent construct may show a larger density-dependent gain in apparent binding or a more persistent washout at high density. A construct with stronger intrinsic affinity should also show stronger binding in an isolated-arm assay, and its affinity advantage need not disappear at low target density.
Functional potency is a supporting observation, not a direct affinity assay. Cell killing, cytokine release, or another response depends on binding plus downstream steps such as receptor organization, signaling, and assay timing. The earlier material on occupancy versus functional potency is relevant here: a functional concentration-response shift cannot, on its own, identify whether affinity or avidity changed.
Worked Example: Interpreting a Target-Density Response Pattern
Two hypothetical bispecifics are tested for cell binding. The apparent concentration for half-maximal binding, \(C_{50,\mathrm{app}}\), is measured at low and high target density. Construct P gives 18 nM at low density and 4.5 nM at high density. Construct Q gives 5.0 nM at low density and 4.0 nM at high density. Monovalent assays show the same isolated-arm \(K_D=12\ \mathrm{nM}\) for both constructs.
For P, the high-to-low density change in \(C_{50,\mathrm{app}}\) is \(4.5/18=0.25\), a fourfold reduction at high density. For Q, it is \(4.0/5.0=0.80\), a 1.25-fold reduction. Since the isolated-arm \(K_D\) values are matched, P's stronger density dependence is more consistent with an avidity contribution than with stronger intrinsic affinity.
The \(C_{50,\mathrm{app}}\) values are descriptive assay parameters, not monovalent \(K_D\) estimates. The pattern supports a mechanistic interpretation only when target-density manipulation has not also changed relevant cell properties and when nonspecific binding and assay timing are controlled.
Controls, Alternatives, and Failure Modes
No single pattern uniquely identifies avidity. The strongest evidence comes from agreement among orthogonal measurements: isolated-arm kinetics, intact-molecule binding over a target-density range, and washout under conditions that limit external rebinding. Where possible, compare constructs with matched architecture, epitope, valency, and labeling. Confirm target abundance independently, and use the same temperature, incubation time, and wash protocol across density conditions.
| Observation | Interpretation it supports | What it cannot establish alone |
|---|---|---|
| Lower isolated-arm \(K_D\) or \(k_{\mathrm{off}}\) | Stronger intrinsic affinity under the assay conditions | Whether intact-molecule avidity also contributes |
| Much slower intact-molecule washout at high target density, with matched isolated-arm kinetics | Avidity or density-dependent rebinding | A unique avidity mechanism without controls for internalization and target turnover |
| Lower cell-binding \(C_{50,\mathrm{app}}\) or improved functional potency | Stronger apparent engagement or response in that assay | Intrinsic affinity, or avidity, as the sole cause |
A density-dependent change in washout is especially informative when free antibody is removed effectively. Residual antibody in the medium can rebind and make dissociation appear slower. Conversely, very rapid flow or a surface configuration that prevents a second arm from reaching a target can suppress avidity. Cell internalization, target shedding, target turnover, and changes in epitope accessibility can also alter the measured signal. If density changes are accompanied by changes in these processes, interpret the result cautiously.
A common mistake is to call a slower cell-surface washout “higher affinity.” That conclusion confuses a multivalent effective dissociation rate with the monovalent \(k_{\mathrm{off}}\). The correction is to measure the isolated arm under a 1:1-compatible assay, then ask whether intact-molecule binding and washout vary with target density in a way that the isolated-arm result cannot explain. Even then, the conclusion is “consistent with avidity” unless competing explanations have been addressed.
The main alternatives answer different questions. A monovalent kinetic assay is the direct choice for intrinsic affinity. Density titration and intact-molecule washout probe the contribution of multivalent engagement in a specified biological setting. Functional response assays establish consequences for activity under their particular conditions, but do not replace either binding measurement. Each method has limitations: isolated arms may not reproduce the intact molecule's geometry, cell-based assays can include trafficking, and apparent response curves combine binding with downstream biology.
Check Your Understanding
Answer each question, then compare with the solutions.
- A monovalent assay gives \(k_{\mathrm{on}}=1.0\times10^5\ \mathrm{M^{-1}s^{-1}}\) and \(k_{\mathrm{off}}=1.0\times10^{-3}\ \mathrm{s^{-1}}\). What is \(K_D\), and what does it mean?
- Two bispecifics have indistinguishable isolated-arm kinetics. One has much slower intact-molecule washout on high-density cells than low-density cells. Which mechanism is supported, and name one alternative explanation.
- Why is a fourfold reduction in cell-binding \(C_{50,\mathrm{app}}\) insufficient to claim a fourfold increase in intrinsic affinity?
- In the conditional two-state model, what fraction is doubly bound when \(K_D=5\ \mathrm{nM}\) and \(C_{\mathrm{eff}}=15\ \mathrm{nM}\)?
Solutions. (1) \(K_D=(1.0\times10^{-3})/(1.0\times10^5)=1.0\times10^{-8}\ \mathrm{M}=10\ \mathrm{nM}\). Under the simple 1:1 model, this is the equilibrium dissociation constant for the isolated interaction. (2) The density-dependent slowing, with unchanged isolated-arm kinetics, supports avidity or rebinding. Internalization or density-dependent target turnover is one alternative. (3) Cell \(C_{50,\mathrm{app}}\) can reflect valency, target density, rebinding, and assay conditions, not only monovalent affinity. (4) \(f=15/(5+15)=0.75\), so the model predicts 75% doubly bound among anchored molecules.